Day: 20. June 2017

RIKEN Genesis and Mitsui Knowledgy Industry will offer sequencing service for cancer personalized treatment from July 2017

The service is based on RIKEN Genesis OncoPrime Basic test carried out at RIKEN Genesis Innovation Genome Center in Kawasaki and will first be limited to four national university hospitals (Tokyo University, Okayama University, Hokkaido University and Chiba University), to be eventually extended to 10 university hospitals. RIKEN Genesis is an affiliate company of Sysmex […]

Transgenic licenses Alzheimer model mouse from Osaka City University, offers non-clinical trials

Transgenic, a startup focused on genetic testing, signed a non-exclusive licnese for a recombinant model mouse for Alzheimer’s disease developed by Hiroshi MORI of Osaka City University. The model mouse carries an amyloid β precursor protein (APP) gene mutation uniquely found in patients with familial Alzheimer’s disease. In these mice, Aβ oligomers are formed, and […]

Scroll to top